You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
爾康製藥(300267.SZ):擬設立控股孫公司素康生物
格隆匯 01-08 18:00

格隆匯 1 月 8日丨爾康製藥(300267.SZ)公佈,為充分利用產業及政策優勢,提升公司資源綜合開發及利用能力,拓展公司市場規模,做大做強主業,挖掘新的利潤增長點,公司全資子公司香港爾康擬與自然人陳菂共同出資,在江蘇省連雲港綜合保税區(“連雲港綜保區”)設立控股子公司素康生物,註冊資本3500萬美元,其中,香港爾康認繳出資3465萬美元,陳菂認繳出資35萬美元。

公司擬在連雲港綜保區投資設立控股孫公司,計劃利用產業及政策優勢,藉助連雲港綜保區優越的港口航運物流及保税加工優勢,充分發揮自身研發優勢,投資建設多功能輔料等產業化項目。一方面,提升公司資源綜合開發和利用能力,拓展市場規模,豐富產品品類,創造新的利潤增長點;另一方面,有效鏈接公司相關產品生產項目,充分利用現有資源,提高加工副產物附加值的同時,控制生產經營綜合成本,做大做強主業,實現良好效益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account